Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Mycotopia Therapies Inc
(OP:
TPIA
)
0.0310
+0.0032 (+11.51%)
Streaming Delayed Price
Updated: 11:00 AM EDT, Aug 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
10,480
Open
0.0400
Bid (Size)
N/A (0)
Ask (Size)
N/A (0)
Prev. Close
0.0278
Today's Range
0.0310 - 0.0400
52wk Range
0.0130 - 0.1799
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Psyched: Medical Psychedelics In Davos, Canadian Sen Does Psychedelics, Ei.Ventures & Mycotopia To Merge Into $383M Company
May 24, 2022
Medical Psychedelics have made it into Davos, just in time for the World Economic Forum.
Via
Benzinga
Ehave's Mycotopia Therapies To Merge With Ei.Ventures To Form PSLY.COM
May 23, 2022
Mycotopia Therapies (OTCPK:TPIA) subsidiary of Ehave, Inc. (OTCPK:EHVVF), has signed a definitive agreement to complete a triangular merger with Ei.Ventures, to form PSLY.COM. The companies anticipate...
Via
Benzinga
Performance
YTD
+93.75%
+93.75%
1 Month
+6.53%
+6.53%
3 Month
-46.55%
-46.55%
6 Month
+131.34%
+131.34%
1 Year
-38.00%
-38.00%
More News
Read More
Ei.Ventures And Mycotopia To Merge Into New Psychedelic Mushroom Company
May 20, 2022
Via
Benzinga
Mycotopia Therapies Expands Supply Agreement With HAVN Life Sciences To Include Functional Mushrooms & Other Products
March 21, 2022
Via
Benzinga
Psychedelic Medicine Is On The Rise And Retail Investors Can Own A Piece Of This Groundbreaking Company
March 15, 2022
Via
Benzinga
Could Mushrooms Treat Mental Health Disorders? This Company Thinks It Found the Key And Retail Investors Can Help
March 15, 2022
Via
Benzinga
Psychedelics Stock Mycotopia Plunges On LOI To Merge With Ei.Ventures, A $360M Transaction
December 08, 2021
Via
Benzinga
Psyched: Cybin Gets $9 Price Target, FSD Pharma Acquires Lucid, New Trials From Psilera, Awakn, PharmaDrug And Braxia, California Bill Put On Hold
August 30, 2021
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.